Skip to main content

Advertisement

Log in

Protective and pathogenic roles of CD8+ T cells in atherosclerosis

  • Invited Review
  • Published:
Basic Research in Cardiology Aims and scope Submit manuscript

Abstract

Although infiltration of CD8+ T cells in human atherosclerotic lesions has been described 30 years ago, the role of these cells in lesion development has long remained enigmatic. While experimental models hinted at their pro-atherogenic role based on circumstantial evidence, genetic mouse models of cytotoxic CD8+ T cell-specific immune deficiency suggested no crucial role of these cells in lesion development. However, in recent years, more refined models of adoptive cell transfer, disruption of specific immune regulatory pathways or monoclonal antibody-mediated cell depletion have proposed both atheroprotective and pro-atherogenic functions for CD8+ T cells in atherosclerosis. In particular, MHC class I-restricted CD8+ T cell responses may protect from atherosclerosis, and Qa-1 restricted regulatory CD8+ T cells have been defined. In addition, regulatory CD8+CD25+ T cells possess atheroprotective properties. However, CD8+ T cells can also promote monopoiesis in hyperlipidemia, and exert prototypical cytotoxic functions to promote vascular inflammation and macrophage accumulation leading to atherosclerotic lesion development. Here, we review these findings, mostly from experimental studies that reveal a previously unrecognized complexity and important role of CD8+ T cells in atherosclerosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ait-Oufella H, Sage AP, Mallat Z, Tedgui A (2014) Adaptive (T and B cells) immunity and control by dendritic cells in atherosclerosis. Circ Res 114:1640–1660. doi:10.1161/CIRCRESAHA.114.302761

    Article  CAS  PubMed  Google Scholar 

  2. Akiba H, Takeda K, Kojima Y, Usui Y, Harada N, Yamazaki T, Ma J, Tezuka K, Yagita H, Okumura K (2005) The role of ICOS in the CXCR5+ follicular B helper T cell maintenance in vivo. J Immunol 175:2340–2348

    Article  CAS  PubMed  Google Scholar 

  3. Barry M, Bleackley RC (2002) Cytotoxic T lymphocytes: all roads lead to death. Nat Rev Immunol 2:401–409. doi:10.1038/nri819

    CAS  PubMed  Google Scholar 

  4. Bevan MJ (2004) Helping the CD8(+) T-cell response. Nat Rev Immunol 4:595–602. doi:10.1038/nri1413

    Article  CAS  PubMed  Google Scholar 

  5. Bisikirska B, Colgan J, Luban J, Bluestone JA, Herold KC (2005) TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+ CD25+ Tregs. J Clin Invest 115:2904–2913. doi:10.1172/JCI23961

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Campbell LA, Rosenfeld ME (2015) Infection and atherosclerosis development. Arch Med Res 46:339–350. doi:10.1016/j.arcmed.2015.05.006

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Chess L, Jiang H (2004) Resurrecting CD8+ suppressor T cells. Nat Immunol 5:469–471. doi:10.1038/ni0504-469

    Article  CAS  PubMed  Google Scholar 

  8. Churlaud G, Pitoiset F, Jebbawi F, Lorenzon R, Bellier B, Rosenzwajg M, Klatzmann D (2015) Human and mouse CD8(+)CD25(+)FOXP3(+) regulatory T cells at steady state and during interleukin-2 therapy. Front Immunol 6:171. doi:10.3389/fimmu.2015.00171

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Chyu KY, Zhao X, Dimayuga PC, Zhou J, Li X, Yano J, Lio WM, Chan LF, Kirzner J, Trinidad P, Cercek B, Shah PK (2012) CD8+ T cells mediate the athero-protective effect of immunization with an ApoB-100 peptide. PLoS One 7:e30780. doi:10.1371/journal.pone.0030780

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Clement M, Guedj K, Andreata F, Morvan M, Bey L, Khallou-Laschet J, Gaston AT, Delbosc S, Alsac JM, Bruneval P, Deschildre C, Le Borgne M, Castier Y, Kim HJ, Cantor H, Michel JB, Caligiuri G, Nicoletti A (2015) Control of the T follicular helper-germinal center B-cell axis by CD8(+) regulatory T cells limits atherosclerosis and tertiary lymphoid organ development. Circulation 131:560–570. doi:10.1161/CIRCULATIONAHA.114.010988

    Article  CAS  PubMed  Google Scholar 

  11. Cochain C, Chaudhari SM, Koch M, Wiendl H, Eckstein HH, Zernecke A (2014) Programmed cell death-1 deficiency exacerbates T cell activation and atherogenesis despite expansion of regulatory T cells in atherosclerosis-prone mice. PLoS One 9:e93280. doi:10.1371/journal.pone.0093280

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Cochain C, Koch M, Chaudhari SM, Busch M, Pelisek J, Boon L, Zernecke A (2015) CD8+ T cells regulate monopoiesis and circulating Ly6C-high monocyte levels in atherosclerosis in mice. Circ Res 117:244–253. doi:10.1161/CIRCRESAHA.117.304611

    Article  CAS  PubMed  Google Scholar 

  13. Cochain C, Zernecke A (2015) Macrophages and immune cells in atherosclerosis: recent advances and novel concepts. Basic Res Cardiol 110:34. doi:10.1007/s00395-015-0491-8

    Article  CAS  PubMed  Google Scholar 

  14. Combadiere C, Potteaux S, Rodero M, Simon T, Pezard A, Esposito B, Merval R, Proudfoot A, Tedgui A, Mallat Z (2008) Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 117:1649–1657. doi:10.1161/CIRCULATIONAHA.107.745091

    Article  CAS  PubMed  Google Scholar 

  15. Elhage R, Gourdy P, Brouchet L, Jawien J, Fouque MJ, Fievet C, Huc X, Barreira Y, Couloumiers JC, Arnal JF, Bayard F (2004) Deleting TCR alpha beta+ or CD4+ T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice. Am J Pathol 165:2013–2018

    Article  PubMed  PubMed Central  Google Scholar 

  16. Ensan S, Li A, Besla R, Degousee N, Cosme J, Roufaiel M, Shikatani EA, El-Maklizi M, Williams JW, Robins L, Li C, Lewis B, Yun TJ, Lee JS, Wieghofer P, Khattar R, Farrokhi K, Byrne J, Ouzounian M, Zavitz CC, Levy GA, Bauer CM, Libby P, Husain M, Swirski FK, Cheong C, Prinz M, Hilgendorf I, Randolph GJ, Epelman S, Gramolini AO, Cybulsky MI, Rubin BB, Robbins CS (2016) Self-renewing resident arterial macrophages arise from embryonic CX3CR1(+) precursors and circulating monocytes immediately after birth. Nat Immunol 17:159–168. doi:10.1038/ni.3343

    Article  CAS  PubMed  Google Scholar 

  17. Filardo S, Di Pietro M, Farcomeni A, Schiavoni G, Sessa R (2015) Chlamydia pneumoniae-mediated inflammation in atherosclerosis: a meta-analysis. Mediators Inflamm 2015:378658. doi:10.1155/2015/378658

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Fyfe AI, Qiao JH, Lusis AJ (1994) Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet. J Clin Invest 94:2516–2520. doi:10.1172/JCI117622

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Geissmann F, Jung S, Littman DR (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19:71–82

    Article  CAS  PubMed  Google Scholar 

  20. Getz GS, Reardon CA (2012) Animal models of atherosclerosis. Arterioscler Thromb Vasc Biol 32:1104–1115. doi:10.1161/ATVBAHA.111.237693

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Gewaltig J, Kummer M, Koella C, Cathomas G, Biedermann BC (2008) Requirements for CD8 T-cell migration into the human arterial wall. Hum Pathol 39:1756–1762. doi:10.1016/j.humpath.2008.04.018

    Article  CAS  PubMed  Google Scholar 

  22. Grivel JC, Ivanova O, Pinegina N, Blank PS, Shpektor A, Margolis LB, Vasilieva E (2011) Activation of T lymphocytes in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 31:2929–2937. doi:10.1161/ATVBAHA.111.237081

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Honjo T, Chyu KY, Dimayuga PC, Yano J, Lio WM, Trinidad P, Zhao X, Zhou J, Chen S, Cercek B, Arditi M, Shah PK (2015) ApoB-100-related peptide vaccine protects against angiotensin II-induced aortic aneurysm formation and rupture. J Am Coll Cardiol 65:546–556. doi:10.1016/j.jacc.2014.11.054

    Article  CAS  PubMed  Google Scholar 

  24. Hopkins PN (2013) Molecular biology of atherosclerosis. Physiol Rev 93:1317–1542. doi:10.1152/physrev.00004.2012

    Article  CAS  PubMed  Google Scholar 

  25. Hu D, Ikizawa K, Lu L, Sanchirico ME, Shinohara ML, Cantor H (2004) Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat Immunol 5:516–523. doi:10.1038/ni1063

    Article  CAS  PubMed  Google Scholar 

  26. Hu D, Mohanta SK, Yin C, Peng L, Ma Z, Srikakulapu P, Grassia G, MacRitchie N, Dever G, Gordon P, Burton FL, Ialenti A, Sabir SR, McInnes IB, Brewer JM, Garside P, Weber C, Lehmann T, Teupser D, Habenicht L, Beer M, Grabner R, Maffia P, Weih F, Habenicht AJ (2015) Artery tertiary lymphoid organs control aorta immunity and protect against atherosclerosis via vascular smooth muscle cell lymphotoxin beta receptors. Immunity 42:1100–1115. doi:10.1016/j.immuni.2015.05.015

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Hwang Y, Yu HT, Kim DH, Jang J, Kim HY, Kang I, Kim HC, Park S, Lee WW (2016) Expansion of CD8(+) T cells lacking the IL-6 receptor alpha chain in patients with coronary artery diseases (CAD). Atherosclerosis 249:44–51. doi:10.1016/j.atherosclerosis.2016.03.038

    Article  CAS  PubMed  Google Scholar 

  28. Jansen MF, Hollander MR, van Royen N, Horrevoets AJ, Lutgens E (2016) CD40 in coronary artery disease: a matter of macrophages? Basic Res Cardiol 111:38. doi:10.1007/s00395-016-0554-5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Jiang H, Canfield SM, Gallagher MP, Jiang HH, Jiang Y, Zheng Z, Chess L (2010) HLA-E-restricted regulatory CD8(+) T cells are involved in development and control of human autoimmune type 1 diabetes. J Clin Invest 120:3641–3650. doi:10.1172/JCI43522

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Joffre OP, Segura E, Savina A, Amigorena S (2012) Cross-presentation by dendritic cells. Nat Rev Immunol 12:557–569. doi:10.1038/nri3254

    Article  CAS  PubMed  Google Scholar 

  31. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK (1986) Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6:131–138

    Article  CAS  PubMed  Google Scholar 

  32. Keul P, Lucke S, von Wnuck Lipinski K, Bode C, Graler M, Heusch G, Levkau B (2011) Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte/macrophages in inflammation and atherosclerosis. Circ Res 108:314–323. doi:10.1161/CIRCRESAHA.110.235028

    Article  CAS  PubMed  Google Scholar 

  33. Kim HJ, Verbinnen B, Tang X, Lu L, Cantor H (2010) Inhibition of follicular T-helper cells by CD8(+) regulatory T cells is essential for self tolerance. Nature 467:328–332. doi:10.1038/nature09370

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Kimura T, Tse K, Sette A, Ley K (2015) Vaccination to modulate atherosclerosis. Autoimmunity 48:152–160. doi:10.3109/08916934.2014.1003641

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Klingenberg R, Lebens M, Hermansson A, Fredrikson GN, Strodthoff D, Rudling M, Ketelhuth DF, Gerdes N, Holmgren J, Nilsson J, Hansson GK (2010) Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis. Arterioscler Thromb Vasc Biol 30:946–952. doi:10.1161/ATVBAHA.109.202671

    Article  CAS  PubMed  Google Scholar 

  36. Koch AE, Haines GK, Rizzo RJ, Radosevich JA, Pope RM, Robinson PG, Pearce WH (1990) Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response. Am J Pathol 137:1199–1213

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Kolbus D, Ljungcrantz I, Andersson L, Hedblad B, Fredrikson GN, Bjorkbacka H, Nilsson J (2013) Association between CD8+ T-cell subsets and cardiovascular disease. J Intern Med 274:41–51. doi:10.1111/joim.12038

    Article  CAS  PubMed  Google Scholar 

  38. Kolbus D, Ramos OH, Berg KE, Persson J, Wigren M, Bjorkbacka H, Fredrikson GN, Nilsson J (2010) CD8+ T cell activation predominate early immune responses to hypercholesterolemia in Apoe(−)(/)(−) mice. BMC Immunol 11:58. doi:10.1186/1471-2172-11-58

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Kyaw T, Winship A, Tay C, Kanellakis P, Hosseini H, Cao A, Li P, Tipping P, Bobik A, Toh BH (2013) Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient mice. Circulation 127:1028–1039. doi:10.1161/CIRCULATIONAHA.112.001347

    Article  CAS  PubMed  Google Scholar 

  40. Legein B, Janssen EM, Theelen TL, Gijbels MJ, Walraven J, Klarquist JS, Hennies CM, Wouters K, Seijkens TT, Wijnands E, Sluimer JC, Lutgens E, Zenke M, Hildner K, Biessen EA, Temmerman L (2015) Ablation of CD8alpha(+) dendritic cell mediated cross-presentation does not impact atherosclerosis in hyperlipidemic mice. Sci Rep 5:15414. doi:10.1038/srep15414

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Lievens D, Habets KL, Robertson AK, Laouar Y, Winkels H, Rademakers T, Beckers L, Wijnands E, Boon L, Mosaheb M, Ait-Oufella H, Mallat Z, Flavell RA, Rudling M, Binder CJ, Gerdes N, Biessen EA, Weber C, Daemen MJ, Kuiper J, Lutgens E (2013) Abrogated transforming growth factor beta receptor II (TGFbetaRII) signalling in dendritic cells promotes immune reactivity of T cells resulting in enhanced atherosclerosis. Eur Heart J 34:3717–3727. doi:10.1093/eurheartj/ehs106

    Article  CAS  PubMed  Google Scholar 

  42. Lindau A, Hardtner C, Hergeth SP, Blanz KD, Dufner B, Hoppe N, Anto-Michel N, Kornemann J, Zou J, Gerhardt LM, Heidt T, Willecke F, Geis S, Stachon P, Wolf D, Libby P, Swirski FK, Robbins CS, McPheat W, Hawley S, Braddock M, Gilsbach R, Hein L, von zur Muhlen C, Bode C, Zirlik A, Hilgendorf I (2016) Atheroprotection through SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progression. Basic Res Cardiol 111:20. doi:10.1007/s00395-016-0535-8

  43. Lochner M, Berod L, Sparwasser T (2015) Fatty acid metabolism in the regulation of T cell function. Trends Immunol 36:81–91. doi:10.1016/j.it.2014.12.005

    Article  CAS  PubMed  Google Scholar 

  44. Ludewig B, Freigang S, Jaggi M, Kurrer MO, Pei YC, Vlk L, Odermatt B, Zinkernagel RM, Hengartner H (2000) Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model. Proc Natl Acad Sci USA 97:12752–12757. doi:10.1073/pnas.220427097

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Mestas J, Hughes CC (2004) Of mice and not men: differences between mouse and human immunology. J Immunol 172:2731–2738

    Article  CAS  PubMed  Google Scholar 

  46. Mohanta SK, Yin C, Peng L, Srikakulapu P, Bontha V, Hu D, Weih F, Weber C, Gerdes N, Habenicht AJ (2014) Artery tertiary lymphoid organs contribute to innate and adaptive immune responses in advanced mouse atherosclerosis. Circ Res 114:1772–1787. doi:10.1161/CIRCRESAHA.114.301137

    Article  CAS  PubMed  Google Scholar 

  47. Nadareishvili ZG, Koziol DE, Szekely B, Ruetzler C, LaBiche R, McCarron R, DeGraba TJ (2001) Increased CD8(+) T cells associated with Chlamydia pneumoniae in symptomatic carotid plaque. Stroke 32:1966–1972

    Article  CAS  PubMed  Google Scholar 

  48. Olofsson PS, Soderstrom LA, Wagsater D, Sheikine Y, Ocaya P, Lang F, Rabu C, Chen L, Rudling M, Aukrust P, Hedin U, Paulsson-Berne G, Sirsjo A, Hansson GK (2008) CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice. Circulation 117:1292–1301. doi:10.1161/CIRCULATIONAHA.107.699173

    Article  CAS  PubMed  Google Scholar 

  49. Qiu MK, Wang SC, Dai YX, Wang SQ, Ou JM, Quan ZW (2015) PD-1 and Tim-3 Pathways Regulate CD8+ T Cells Function in Atherosclerosis. PLoS One 10:e0128523. doi:10.1371/journal.pone.0128523

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Santos M, Schilham MW, Rademakers LH, Marx JJ, de Sousa M, Clevers H (1996) Defective iron homeostasis in beta 2-microglobulin knockout mice recapitulates hereditary hemochromatosis in man. J Exp Med 184:1975–1985

    Article  CAS  PubMed  Google Scholar 

  51. Schurch CM, Riether C, Ochsenbein AF (2014) Cytotoxic CD8+ T cells stimulate hematopoietic progenitors by promoting cytokine release from bone marrow mesenchymal stromal cells. Cell Stem Cell 14:460–472. doi:10.1016/j.stem.2014.01.002

    Article  CAS  PubMed  Google Scholar 

  52. Swirski FK, Libby P, Aikawa E, Alcaide P, Luscinskas FW, Weissleder R, Pittet MJ (2007) Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest 117:195–205. doi:10.1172/JCI29950

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Tabas I, Bornfeldt KE (2016) Macrophage phenotype and function in different stages of atherosclerosis. Circ Res 118:653–667. doi:10.1161/CIRCRESAHA.115.306256

    Article  CAS  PubMed  Google Scholar 

  54. Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, Llodra J, Garin A, Liu J, Mack M, van Rooijen N, Lira SA, Habenicht AJ, Randolph GJ (2007) Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 117:185–194. doi:10.1172/JCI28549

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Xu QB, Oberhuber G, Gruschwitz M, Wick G (1990) Immunology of atherosclerosis: cellular composition and major histocompatibility complex class II antigen expression in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged human specimens. Clin Immunol Immunopathol 56:344–359

    Article  CAS  PubMed  Google Scholar 

  56. Xu S, Liu X, Bao Y, Zhu X, Han C, Zhang P, Zhang X, Li W, Cao X (2012) Constitutive MHC class I molecules negatively regulate TLR-triggered inflammatory responses via the Fps-SHP-2 pathway. Nat Immunol 13:551–559. doi:10.1038/ni.2283

    Article  CAS  PubMed  Google Scholar 

  57. Zafiratos MT, Manam S, Henderson KK, Ramsey KH, Murthy AK (2015) CD8+ T cells mediate Chlamydia pneumoniae-induced atherosclerosis in mice. Pathog Dis. doi:10.1093/femspd/ftv052

    PubMed  PubMed Central  Google Scholar 

  58. Zhou J, Dimayuga PC, Zhao X, Yano J, Lio WM, Trinidad P, Honjo T, Cercek B, Shah PK, Chyu KY (2014) CD8(+)CD25(+) T cells reduce atherosclerosis in apoE(−/−) mice. Biochem Biophys Res Commun 443:864–870. doi:10.1016/j.bbrc.2013.12.057

    Article  CAS  PubMed  Google Scholar 

  59. Zhou X, Stemme S, Hansson GK (1996) Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice. Am J Pathol 149:359–366

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by the Deutsche Forschungsgemeinschaft (SFB688 TPA22).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alma Zernecke.

Ethics declarations

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cochain, C., Zernecke, A. Protective and pathogenic roles of CD8+ T cells in atherosclerosis. Basic Res Cardiol 111, 71 (2016). https://doi.org/10.1007/s00395-016-0589-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00395-016-0589-7

Keywords

Navigation